Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-08

Clinical Trial Update: Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129) [Phase 3]

View source ↗

Summary

Phase 3 trial ANRS129 evaluating the efficacy of combining tenofovir disoproxil fumarate/emtricitabine with efavirenz in HIV-infected patients with tuberculosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sustiva (efavirenz)
  • TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections, Tuberculosis | Phase 3 | Status: COMPLETED